Could a custom tumor map guide better ovarian cancer care?
NCT ID NCT06466382
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Swiss study is testing whether creating a detailed molecular profile of each patient's tumor can help doctors choose more effective treatments for advanced ovarian cancer. Sixty newly diagnosed patients will be randomly assigned to either standard care or a personalized treatment plan recommended by a molecular tumor board. The goal is to see if this tailored approach leads to better tumor response and helps doctors feel more confident in their treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
molecular tumor board recommendation based on tumor profiling
What this could lead to
If successful, this could show that personalized treatment plans based on detailed tumor analysis improve outcomes for ovarian cancer patients who don't respond to standard therapy.
What could go wrong
This is a small pilot study (60 participants) focused on feasibility and early signals, not a large-scale test of effectiveness. The approach may not lead to better survival or quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
HFR-Fribourg- Hopital Cantonal
RECRUITINGFribourg, 1708, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
HOCH Health Ostschweiz Kantonsspital St.Gallen
RECRUITINGSankt Gallen, Canton of St. Gallen, 9007, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Inselspital Bern (University Hospital for Medical Oncology)
RECRUITINGBern, 3010, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kantonsspital Baden AG
RECRUITINGBaden, Canton of Aargau, 5404, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Thurgau AG Frauenfeld / Münsterlingen
RECRUITINGFrauenfeld, Thurgau, 8500, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Zurich
RECRUITINGZurich, 8091, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitätsspital Basel
RECRUITINGBasel, Canton of Basel-City, 4031, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••